Literature DB >> 15846104

Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alpha.

Matthew D Westfall1, Amanda S Joyner, Christopher E Barbieri, Mark Livingstone, Jennifer A Pietenpol.   

Abstract

DeltaNp63alpha, a homologue of the tumor suppressor p53, acts as a transcriptional repressor with dominant negative effects towards p53. Additionally, DeltaNp63alpha is overexpressed in a number of squamous cell carcinomas, suggesting a potential role in oncogenesis. However, the mechanisms regulating p63 have yet to be elucidated. The goal of the current study was to determine the effect of various genotoxic stresses on DeltaNp63alpha posttranslational modification and stability in normal and transformed squamous epithelial cells. We found that DeltaNp63alpha protein levels decreased after ultraviolet radiation and paclitaxel treatment of both normal and transformed cells. After UV and paclitaxel treatment, DeltaNp63alpha phosphorylation was significantly modulated. Additionally, DeltaNp63alpha protein levels were regulated in a proteasome-dependent manner in control and UV treated cells with increased DeltaNp63alpha ubiquitination after UV treatment or proteasome inhibition. Our studies provide insight to a mechanism for DeltaNp63alpha regulation during normal cell proliferation and, in particular, after stress. Further, the inverse regulation of p53 and DeltaNp63alpha protein levels after cell stress through opposing regulation of proteasome-mediated degradation may allow for rapid transcriptional changes of specific target genes that are consistent with the roles of these family members in tumor suppression and cell growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846104     DOI: 10.4161/cc.4.5.1685

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  29 in total

1.  Regulation of ΔNp63α by NFκΒ.

Authors:  Tanusree Sen; Xiaofei Chang; David Sidransky; Aditi Chatterjee
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

Review 2.  Ubiquitin and ubiquitin-like modifications of the p53 family.

Authors:  Ian R Watson; Meredith S Irwin
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

3.  Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation.

Authors:  Yingchun Li; Melissa J Peart; Carol Prives
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

Review 4.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

5.  U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha.

Authors:  Aditi Chatterjee; Sunil Upadhyay; Xiaofei Chang; Jatin K Nagpal; Barry Trink; David Sidransky
Journal:  Cell Cycle       Date:  2008-02-19       Impact factor: 4.534

6.  Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63.

Authors:  Bridget E Ferguson-Yates; Hongyan Li; Tiffany K Dong; Jennifer L Hsiao; Dennis H Oh
Journal:  Carcinogenesis       Date:  2007-11-04       Impact factor: 4.944

7.  The roles of nitric oxide synthase and eIF2alpha kinases in regulation of cell cycle upon UVB-irradiation.

Authors:  Lei Wang; Yan Liu; Shiyong Wu
Journal:  Cell Cycle       Date:  2010-01-05       Impact factor: 4.534

8.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

9.  Expansion of epidermal progenitors with high p63 phosphorylation during wound healing of mouse epidermis.

Authors:  Daisuke Suzuki; Makoto Senoo
Journal:  Exp Dermatol       Date:  2013-05       Impact factor: 3.960

10.  ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy.

Authors:  Kathryn G Eby; Jennifer M Rosenbluth; Deborah J Mays; Clayton B Marshall; Christopher E Barton; Seema Sinha; Kimberly N Johnson; Luojia Tang; Jennifer A Pietenpol
Journal:  Mol Cancer       Date:  2010-04-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.